Valuation, from the filing
| Public float | $2.42B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-03-28 |
|---|---|---|
| Float per share | $41.65 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 16.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 0.7× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-03-28, not today, and each multiple below it uses the figures for the fiscal year ending 2025-09-30 — the year that filing covered.
Valuation over time
16.6× earnings today, against a median of 16.6× across 7 years on record. In line with its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-03-28 | $2.42B | 16.6× | |
| 2021-04-02 | $10.25B | 20.0× | |
| 2020-03-27 | $4.12B | 10.6× | |
| 2019-03-29 | $3.09B | 6.7× | |
| 2018-03-30 | $3.40B | 53.3× | |
| 2017-03-31 | $4.06B | 18.6× | |
| 2016-04-02 | $3.30B | 10.5× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
How this compares in its industry
Percentile among the Agricultural Chemicals filers on this site, highest value first. A high percentile means a large figure, which is good for a margin and not for leverage — the ranking says where the company sits, not whether that is where it should be.
| Measure | Reported | Percentile | |
|---|---|---|---|
| CapEx / revenue | 2.9% | 0th | |
| FCF margin | 8.0% | 75th | |
| Operating margin | 10.5% | 75th | |
| Net margin | 4.3% | 71th | |
| Gross margin | 30.6% | 43th | |
| SBC / revenue | 2.0% | 57th | |
| Current ratio | 1.27x | 44th | |
| Revenue YoY growth | -3.9% | 50th |
SCOTTS MIRACLE-GRO CO (SMG) reported revenue of $3.48B and net income of $73.90M for the fiscal year ended 2026-06-27. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SCOTTS MIRACLE-GRO CO’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Agricultural Chemicals.
Income
| Metric | 2026-06-27 |
|---|---|
| Revenue | $3.48B |
| Cost of revenue | $2.36B |
| Gross profit | $1.11B |
| Operating income | $382.50M |
| Net income | $73.90M |
| Research & development | Unavailable |
| Weighted-average diluted shares | Unavailable |
| Pretax income | $249.40M |
| Income tax expense | $94.50M |
| Diluted EPS | Unavailable |
| Selling, general & administrative | $618.00M |
| General & administrative | Unavailable |
| Selling & marketing | Unavailable |
Balance
| Metric | 2026-06-27 |
|---|---|
| Cash & equivalents | $27.70M |
| Total assets | $3.17B |
| Current assets | $1.35B |
| Total liabilities | $3.38B |
| Current liabilities | $1.11B |
| Total equity incl. NCI | -$208.70M |
| Temporary (mezzanine) equity | Unavailable |
| Inventory | $481.40M |
| Accounts receivable | $713.00M |
| Goodwill | $243.90M |
| Long-term debt | $1.84B |
| Accounts payable | $310.30M |
Cash flow
| Metric | 2026-06-27 |
|---|---|
| Operating cash flow | $369.30M |
| Capital expenditures | $106.00M |
| Investing cash flow | -$154.20M |
| Financing cash flow | -$237.60M |
| Net change in cash | -$23.40M |
| Stock-based compensation | $51.70M |
| Common dividends paid | $154.40M |
| Common share repurchases | $12.10M |
| Depreciation & amortization | Unavailable |
Derived
| Metric | 2026-06-27 |
|---|---|
| Free cash flow | $263.30M |
| Gross margin | 31.8% |
| Operating margin | 11.0% |
| FCF margin | 7.6% |
| SBC / revenue | 1.5% |
| Current ratio | 1.21x |
| Revenue YoY growth | 4.6% |
| Net margin | 2.1% |
| R&D / revenue | Unavailable |
| CapEx / revenue | 3.0% |
| Long-term debt / equity | Unavailable |
| Effective tax rate | 37.9% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SMG in the interactive workspace to inspect any figure back to its filing.
Source filings
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.